You have no items in your shopping cart.
Description
Research Area
Images & Validation
−
| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 Cells |
|---|---|
| Biological Origin | Human |
| Biological Activity | B- and T-Lymphocyte Attenuator (BTLA) is a single-pass type I membrane protein containing 1 Ig-like V-type (immunoglobulin-like) domain. BTLA expression is induced during activation of T cells, and BTLA remains expressed on Th1 cells but not Th2 cells. Like PD1 and CTLA4, BTLA interacts with a B7 homolog, B7H4. However, unlike PD-1 and CTLA-4, BTLA displays T-Cell inhibition via interaction with tumor necrosis family receptors (TNF-R), not just the B7 family of cell surface receptors. BTLA is a lymphocyte inhibitory receptor that inhibits lymphocytes during immune response. BTLA also is a ligand for tumor necrosis factor (receptor) superfamily, member 14 (TNFRSF14), also known as herpes virus entry mediator (HVEM). BTLA-HVEM complexes negatively regulate T-cell immune responses. |
| Tag | C-6xHis |
| Expression Region | Lys31-Leu150 |
| MW | 30 KDa (reducing condition) |
| Purity | 98.00% |
| Protein Sequence | Lys31-Leu150 |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Human BTLA Protein, mFc-His Tag [orb689405]
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
The protein has a predicted molecular mass of 41.3 kDa after removal of the signal peptide.
Mammalian
100 μg, 50 μg, 10 μgHuman BTLA Protein, His Tag [orb757467]
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
The protein has a predicted molecular mass of 14.6 kDa after removal of the signal peptide.The apparent molecular mass of Human-BTLA-His is approximately 25-35 kDa due to glycosylation.
Mammalian
10 μg, 100 μg, 50 μgBTLA Protein, Human, Recombinant (His & Avi) [orb1959859]
98.00%
16.7 kDa (predicted). Due to glycosylation, the protein migrates to 35-45 kDa based on Tris-Bis PAGE result.
1 mg, 100 μg, 500 μgBTLA Protein, Human, Recombinant (isoform1, His) [orb1953077]
98.00%
15.19 kDa (predicted); 30.0 kDa (reducing conditions)
1 mg, 100 μgBTLA Protein, Human, Recombinant (His & Avi), Biotinylated [orb1953086]
98.00%
17 kDa (predicted); 37.3 kDa (reducing conditions)
100 μg, 20 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].




